Silvana Canevari (Andrea Anichini)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Disease markers

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

James F Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca S Kristeleit, Rowan E Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Alessandro Massimo Gianni, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary J Doherty, Hannah J Gould, Giulia Pellizzari, Mano Nakamura, Kristina M Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah E Pinder, Heather J Bax, Debra H Josephs, Sophia N Karagiannis
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature communications 14 (1) (2023)
Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, Silvana Canevari, Deborah Lenoci, Federico Pistore, Rosalba Miceli, Stefania Vecchio, Daris Ferrari, Cecilia Moro, Andrea Sponghini, Alessia Caldara, Maria Cossu Rocca, Simona Secondino, Gabriella Moretti, Nerina Denaro, Francesco Caponigro, Emanuela Vaccher, Gaetana Rinaldi, Francesco Ferraù, Paolo Bossi, Lisa Licitra, Loris De Cecco
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer. Cells 11 (19) (2022)
Barbara Frigerio, Elena Luison, Alessandro Desideri, Federico Iacovelli, Chiara Camisaschi, Ettore C Seregni, Silvana Canevari, Alessandro Massimo Gianni
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review. Biomedicines 9 (12) (2021)
Alessandro Satta, Mezzanzanica Delia, Francesco Caroli, Barbara Frigerio, Massimo Di Nicola, Roland E Kontermann, Federico Iacovelli, Alessandro Desideri, Silvana Canevari, Alessandro Massimo Gianni
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells. mAbs 10 (7) (2018)
Paolo Bossi, Marco Siano, Cristiana Bergamini, Maria Cossu Rocca, Andrea P Sponghini, Marco Giannoccaro, Luca Tonella, Alessandro Paoli, Edoardo Marchesi, Federica Perrone, Silvana Pilotti, Laura D Locati, Silvana Canevari, Lisa Licitra, Loris De Cecco
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? Disease markers 2017 (2017)